Lens retrodots and vacuoles positively linked to incidence of cataract surgery

Article

Lens retrodots and vacuoles are positively linked with a 10-year incidence of cataract surgery.

Lens retrodots and vacuoles are positively linked with a 10-year incidence of cataract surgery, reveals a study in the journal Eye.

Dr A.G. Tan et al., Centre for Vision Research, Westmead Millennium Institute and Department of Ophthalmology, University of Sydney, Sydney, Australia, conducted an investigation onto 3654 patients aged 49 years and over. Of the patients included in the study, 2335 were re-assessed after five years and 1952 patients were re-assessed after 10 years.

The correlation between retrodots or vacuoles and the prevalence of 10-year incidence of nuclear, cortical, and posterior subcapsular (PSC) cataract and cataract surgery was analysed.

At baseline, 142 patients had retrodots and 1333 patients had vacuoles. Vacuoles were linked to prevalent PSC cataract at baseline with a 95% confidence interval. Baseline retrodots were linked to an increased incidence of cataract surgery. At baseline, three vacuoles were linked to increased risk of PSC cataract and cataract surgery.

The association between lens retrodots and vacuoles and incidence of cataract surgery suggests risk factors between lens features and the development of PSC cataract.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.